Filing Details

Accession Number:
0000899243-20-027365
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-05 18:49:46
Reporting Period:
2020-10-01
Accepted Time:
2020-10-05 18:49:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1412408 Phreesia Inc. PHR Services-Business Services, Nec (7389) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1776729 David Linetsky C/o Phreesia, Inc.
432 Park Avenue South, 12Th Floor
New York NY 10016
Svp, Life Sciences No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-01 1,377 $4.71 132,554 No 4 M Direct
Common Stock Disposition 2020-10-01 4,222 $30.92 128,332 No 4 S Direct
Common Stock Disposition 2020-10-01 255 $31.84 128,077 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-10-01 1,377 $0.00 1,377 $4.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,626 2028-08-06 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.42 to $31.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. 25% of this option vested and became exercisable on October 17, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.